Individuals Discontinuing Slimming Injections Put On Pounds Four Times Faster Compared to People Using Diet and Exercise

A recent study indicates that individuals who discontinue blockbuster GLP-1 drugs like Wegovy and Mounjaro can put back on reduced body mass much more quickly than those who halt conventional lifestyle programs.

Research printed in a prominent health publication shows that while overweight individuals often shed substantial amounts of their body weight while on the medication, the mass comes back at an average rate of 0.8 kg per month upon discontinuation.

"People using such treatments must be aware of the potential of fast rebound weight gain when the therapy ends," cautioned expert Dr. Susan Jebb.

Such speed of regain suggests a reversion to starting mass in about one and a half years.

Comparing Treatments

The study, which reviewed 37 of trials involving thousands of patients, compared the effects of GLP-1 agonists with conventional dieting.

Scientists point out that people who lose weight through dieting generally have a more gradual creep back—perhaps 0.1 kg a month—post-intervention.

Explaining the Fast Regain

Nutrition scientists believe the mechanism of the jabs is key to understanding the accelerated weight return.

The injections mimic a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.

"Sustained high doses of GLP-1 concentrations several times higher than the body's typical production might result in the body to produce less of its own natural hormone, and may also diminish responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert.

"Withdrawal of this medication results in hunger is no longer kept in check, making binge eating much more probable."

A Lifelong Issue?

The NHS advise the injections for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.

Professionals argue that, due to the likelihood of weight regain, the therapy is often ongoing.

This opinion is reinforced by drug manufacturers, who say that the findings "underscore the chronic nature of obesity," comparing it to managing diseases like diabetes.

Patient Experiences

Users who have stopped the medication describe a sudden return of cravings.

"It was like a trigger that goes on and you're instantly extremely hungry," said an individual.

The struggle is worsened if users have not developed lasting lifestyle or habit changes during treatment.

Growing Interest

Survey data suggest that a significant number of adults in the UK have used these injections in the past year, with interest being substantial.

• Adoption is more common among females than men.
• The middle-aged age group shows the greatest level of interest.
• A large proportion access the drugs through private prescriptions rather than public health services.

In conclusion, experts caution that while these medications are potent agents for shedding pounds, they are not a standalone cure and lasting health benefits relies on integrated behavioural management.